SBRA vs WELL: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: SBRA is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. SBRA and WELL share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined SBRA and WELL exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Sabra Health Care REIT is a self-managed real estate investment trust that owns and invests in healthcare property, including skilled nursing and transitional care facilities, managed senior housing communities, behavioral health, and specialty hospitals, spread across the United States and Canada. Its portfolio mixes triple-net leases (where operators pay Sabra fixed rent) with managed senior housing under RIDEA-style structures that give Sabra direct exposure to the operating income of those communities, so a chunk of its results moves with occupancy and rate trends in senior living.

Full SBRA guide

Welltower Inc. is the largest healthcare REIT in the world, owning a portfolio of senior housing, assisted living, post-acute and long-term care, and outpatient medical real estate across the United States, the United Kingdom, and Canada. It makes money in two main ways: through its Senior Housing Operating Portfolio (SHOP), where it shares directly in the net operating income that property operators generate from residents, and through rents on triple-net leased seniors housing and care facilities plus outpatient medical buildings. Because SHOP income flows through to Welltower rather than being fixed rent, rising occupancy and room rates translate quickly into higher earnings, which is why the operating portfolio has become the company's main growth engine.

Full WELL guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• SBRA drivers: Senior housing operating recovery; Investment pipeline and acquisitions.
• WELL drivers: Aging-demographics senior-housing tailwind; Operating-portfolio NOI growth.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Sabra depends heavily on the financial health of its tenant operators, and skilled nursing operators in particular run on thin margins tied to Medicare and Medicaid reimbursement, so rate changes or operator distress can pressure rent collection. For WELL, welltower's share price is sensitive to interest rates, since higher rates raise borrowing costs and make REIT dividend yields less competitive against bonds.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick SBRA if you believe its drivers more; WELL if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the SBRA and WELL guides.

SBRA. At $19.41 on October 16, 2026, the shares trade at roughly 12 times annualized second-quarter normalized AFFO and about 1.8 times book value; GAAP P/E figures (about 78 trailing) are distorted by depreciation and the second-quarter reserve and say little about a REIT. The $0.30 quarterly dividend is about 75% of normalized AFFO, leaving some cushion. Third-quarter results on November 4, 2026 will show whether same-store senior housing NOI growth stays in the low-to-mid teens and how quickly the new acquisitions add to AFFO.

WELL. Healthcare REITs are valued on funds from operations (FFO) rather than EPS, because standard net income is weighed down by large non-cash depreciation charges on real estate; that is why Welltower's GAAP P/E near 106x looks extreme. The key operating metric is senior-housing same-store NOI growth, now expected around 19% for 2026. At about $170 billion and a 1.45% yield, Welltower still carries a notably higher multiple than most healthcare REIT peers, and that premium is part of the investment case and part of the risk.

Headline figures (approximate, October 2026): SBRA shows market cap ~$5.0B, revenue (ttm) ~$864M (+25% y/y in Q2 2026), normalized affo/share (q2 2026) $0.40 (+5% y/y), normalized ffo/share (q2 2026) $0.38; WELL shows revenue (ttm) ~$12.8 billion; Q2 2026 ~$3.54 billion, up ~39% YoY, net income (ttm) ~$1.55 billion GAAP (EPS ~$2.23), normalized ffo per share (2025) $5.29 (+~22.5%), 2026 senior-housing same-store noi growth ~19% expected after a raised outlook (original range 15% to 21%).

SBRA and WELL are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined SBRA and WELL exposure against your real portfolio. It is not an investment adviser.